Sale of Fullerton Health draws eight non-binding bids in 1st round: sources
Singapore
SIX years since Fullerton Healthcare Corp (Fullerton Health) ditched its much-publicised plan to list on the Singapore Exchange, its owners have put the corporate healthcare solutions firm on the block, even as signs of liquidity strain threaten to cloud its prospects.
But while healthcare-focussed firms seem all the rage now owing to the Covid-19 pandemic, the sale of Fullerton Health may be facing setbacks, particularly valuation-wise due to among other things, its somewhat complicated capital structure, The Business Times (BT) understands.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Prudential shutters Hong Kong wealth unit Pulse
Singapore has to be realistic on global trends plaguing its stock market: DPM Wong
Google DeepMind unveils next generation of drug discovery AI model
AEM Holdings Q1 net profit tumbles 85% to S$2.4 million
World’s biggest tea buyer Lipton’s sale of last farms is a strategy shift
JPMorgan, Nomura limit Segantii exposure on Hong Kong case